Skip Nav Destination
Issues
15 June 2022
-
Cover Image
Cover Image
![issue cover]()
The cover shows sections of clinical specimens from osteosarcoma and Ewing sarcoma patients. Immunohistochemical staining with D2-40 antibody shows podoplanin expression on the cellular membrane, which is observed in more than half of osteosarcoma cases. Targeting podoplanin with the humanized neutralizing antibody against podoplanin could be a novel therapeutic strategy for podoplanin-positive osteosarcoma. For details, see the article by Takemoto and colleagues on page 2633 of this issue.Close Modal - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
CCR Drug Updates
FDA Approval Summary: Belumosudil for Adult and Pediatric Patients 12 Years and Older with Chronic GvHD after Two or More Prior Lines of Systemic Therapy
Donna Przepiorka; Robert Q. Le; Alexei Ionan; Ruo-Jing Li; Ying-Hong Wang; Ramadevi Gudi; Soumya Mitra; Jonathon Vallejo; Olanrewaju O. Okusanya; Lian Ma; Yuching Yang; Paresma Patel; Djelila Mezaache; Rakhi Shah; Anamitro Banerjee; Sherita McLamore; Adam N. Maung; Kirsten B. Goldberg; Richard Pazdur; Marc R. Theoret; R. Angelo De Claro
Perspectives
Report of the First International Symposium on NUT Carcinoma
Christopher A. French; Michael L. Cheng; Glenn J. Hanna; Steven G. DuBois; Nicole G. Chau; Christine L. Hann; Simone Storck; Ravi Salgia; Matteo Trucco; Jennifer Tseng; Anastasios Stathis; Richard Piekarz; Ulrich M. Lauer; Christophe Massard; Kelly Bennett; Shodeinde Coker; Ulrike Tontsch-Grunt; Martin L. Sos; Sida Liao; Catherine J. Wu; Kornelia Polyak; Sarina A. Piha-Paul; Geoffrey I. Shapiro
Clinical Trials: Targeted Therapy
ASCEND-7: Efficacy and Safety of Ceritinib Treatment in Patients with ALK-Positive Non–Small Cell Lung Cancer Metastatic to the Brain and/or Leptomeninges
Laura Q.M. Chow; Fabrice Barlesi; Erin M. Bertino; Martin J. van den Bent; Heather A. Wakelee; Patrick Y. Wen; Chao-Hua Chiu; Sergey Orlov; Rita Chiari; Margarita Majem; Mark McKeage; Chong-Jen Yu; Pilar Garrido; Felipe K. Hurtado; Pilar Cazorla Arratia; Yuanbo Song; Fabrice Branle; Michael Shi; Dong-Wan Kim
ARRY-382 in Combination with Pembrolizumab in Patients with Advanced Solid Tumors: Results from a Phase 1b/2 Study
Melissa Johnson; Arkadiusz Z. Dudek; Ammar Sukari; Justin Call; Paul R. Kunk; Karl Lewis; Justin F. Gainor; John Sarantopoulos; Patrice Lee; Adele Golden; Allison Harney; S. Michael Rothenberg; Yuanyuan Zhang; Jonathan W. Goldman
Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial
C. Mircea S. Tesileanu; Marc Sanson; Wolfgang Wick; Alba A. Brandes; Paul M. Clement; Sara C. Erridge; Michael A. Vogelbaum; Anna K. Nowak; Jean-Francois Baurain; Warren P. Mason; Helen Wheeler; Olivier L. Chinot; Sanjeev Gill; Matthew Griffin; Leland Rogers; Walter Taal; Roberta Rudà; Michael Weller; Catherine McBain; Myra E. van Linde; Kenneth Aldape; Robert B. Jenkins; Johan M. Kros; Pieter Wesseling; Andreas von Deimling; Youri Hoogstrate; Iris de Heer; Peggy N. Atmodimedjo; Hendrikus J. Dubbink; Rutger W.W. Brouwer; Wilfred F.J. van IJcken; Kin Jip Cheung; Vassilis Golfinopoulos; Brigitta G. Baumert; Thierry Gorlia; Pim J. French; Martin J. van den Bent
Preclinical and Pilot Study of Type I FLT3 Tyrosine Kinase Inhibitor, Crenolanib, with Sorafenib in Acute Myeloid Leukemia and FLT3-Internal Tandem Duplication
Hiroto Inaba; Jolieke G. van Oosterwijk; John C. Panetta; Lie Li; Daelynn R. Buelow; James S. Blachly; Sheila Shurtleff; Ching-Hon Pui; Raul C. Ribeiro; Jeffrey E. Rubnitz; Stanley Pounds; Sharyn D. Baker
Clinical Trials: Immunotherapy
Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial
Gontran Verset; Ivan Borbath; Mark Karwal; Chris Verslype; Hans Van Vlierberghe; Adel Kardosh; Vittorina Zagonel; Per Stal; Debashis Sarker; Daniel H. Palmer; Arndt Vogel; Julien Edeline; Stephane Cattan; Masatoshi Kudo; Ann-Lii Cheng; Sadahisa Ogasawara; Bruno Daniele; Stephen L. Chan; Jennifer J. Knox; Shukui Qin; Abby B. Siegel; Michael Chisamore; Ken Hatogai; Anran Wang; Richard S. Finn; Andrew X. Zhu
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma
Markus W. Löffler; Stefania Gori; Francesco Izzo; Andrea Mayer-Mokler; Paolo A. Ascierto; Alfred Königsrainer; Yuk Ting Ma; Bruno Sangro; Sven Francque; Luisa Vonghia; Alessandro Inno; Antonio Avallone; Jörg Ludwig; Diego Duarte Alcoba; Christian Flohr; Katrin Aslan; Regina Mendrzyk; Heiko Schuster; Marco Borrelli; Danila Valmori; Tanguy Chaumette; Regina Heidenreich; Cécile Gouttefangeas; Greta Forlani; Maria Tagliamonte; Caterina Fusco; Roberta Penta; Mercedes Iñarrairaegui; Ulrike Gnad-Vogt; Carsten Reinhardt; Toni Weinschenk; Roberto S. Accolla; Harpreet Singh-Jasuja; Hans-Georg Rammensee; Luigi Buonaguro
Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
Lakshmi Nayak; Nathan Standifer; Jorg Dietrich; Jennifer L. Clarke; Gavin P. Dunn; Michael Lim; Timothy Cloughesy; Hui K. Gan; Elizabeth Flagg; Elizabeth George; Sarah Gaffey; Julia Hayden; Christina Holcroft; Patrick Y. Wen; Mary Macri; Andrew J. Park; Toni Ricciardi; Aileen Ryan; Paul Schwarzenberger; Ralph Venhaus; Melissa de los Reyes; Nicholas M. Durham; Todd Creasy; Raymond Y. Huang; Thomas Kaley; David A. Reardon
Precision Medicine and Imaging
Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer
Kim R.M. Blenman; Michal Marczyk; Thomas Karn; Tao Qing; Xiaotong Li; Vignesh Gunasekharan; Vesal Yaghoobi; Yalai Bai; Eiman Y. Ibrahim; Tristen Park; Andrea Silber; Denise M. Wolf; Emily Reisenbichler; Carsten Denkert; Bruno V. Sinn; Mariya Rozenblit; Julia Foldi; David L. Rimm; Sibylle Loibl; Lajos Pusztai
A Machine Learning Model Based on Tumor and Immune Biomarkers to Predict Undetectable MRD and Survival Outcomes in Multiple Myeloma
Camila Guerrero; Noemi Puig; Maria-Teresa Cedena; Ibai Goicoechea; Cristina Perez; Juan-José Garcés; Cirino Botta; Maria-Jose Calasanz; Norma C. Gutierrez; Maria-Luisa Martin-Ramos; Albert Oriol; Rafael Rios; Miguel-Teodoro Hernandez; Rafael Martinez-Martinez; Joan Bargay; Felipe de Arriba; Luis Palomera; Ana Pilar Gonzalez-Rodriguez; Adrian Mosquera-Orgueira; Marta-Sonia Gonzalez-Perez; Joaquin Martinez-Lopez; Juan-José Lahuerta; Laura Rosiñol; Joan Blade; Maria-Victoria Mateos; Jesus F. San-Miguel; Bruno Paiva; on behalf of the Programa para el Estudio de la Terapéutica en Hemopatías Malignas (PETHEMA)/Grupo Español de Mieloma (GEM) cooperative study group
Rapid Screening Using Pathomorphologic Interpretation to Detect BRAFV600E Mutation and Microsatellite Instability in Colorectal Cancer
Satoshi Fujii; Daisuke Kotani; Masahiro Hattori; Masato Nishihara; Toshihide Shikanai; Junji Hashimoto; Yuki Hama; Takuya Nishino; Mizuto Suzuki; Ayatoshi Yoshidumi; Makoto Ueno; Yoshito Komatsu; Toshiki Masuishi; Hiroki Hara; Taito Esaki; Yoshiaki Nakamura; Hideaki Bando; Tomoyuki Yamada; Takayuki Yoshino
Translational Cancer Mechanisms and Therapy
Targeting Podoplanin for the Treatment of Osteosarcoma
Ai Takemoto; Satoshi Takagi; Takao Ukaji; Nobuhiko Gyobu; Mamoru Kakino; Miho Takami; Asami Kobayashi; Marie Lebel; Tokuichi Kawaguchi; Minoru Sugawara; Kazue Tsuji-Takayama; Kenji Ichihara; Yuki Funauchi; Keisuke Ae; Seiichi Matsumoto; Yoshiya Sugiura; Kengo Takeuchi; Tetsuo Noda; Ryohei Katayama; Naoya Fujita
AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma
Erin G. Reid; Kelly Shimabukuro; Page Moore; Richard F. Ambinder; Jack D. Bui; Semi Han; Otoniel Martínez-Maza; Dirk P. Dittmer; David Aboulafia; Elizabeth Yu Chiao; Toby Maurer; Robert Baiocchi; Ronald Mitsuyasu; William Wachsman; for the AIDS Malignancy Consortium (AMC)
Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
Clare Vesely; Yien Ning Sophia Wong; Alexa Childs; Ayse U. Akarca; Pawan Dhami; Heli Vaikkinen; Lucia Conde; Javier Herrero; Olagunju Ogunbiyi; Amir Gander; Tu Vinh Luong; Chrissie Thirlwell; Martyn Caplin; Christos Toumpanakis; Karl Peggs; Sergio A. Quezada; Teresa Marafioti; Tim Meyer
The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma
Smita Sihag; Samuel C. Nussenzweig; Henry S. Walch; Meier Hsu; Kay See Tan; Sergio De La Torre; Yelena Y. Janjigian; Steven B. Maron; Geoffrey Y. Ku; Laura H. Tang; Pari M. Shah; Abraham Wu; David R. Jones; David B. Solit; Nikolaus Schultz; Karuna Ganesh; Michael F. Berger; Daniela Molena
Exploratory Study of NPC-0501 Trial: Optimal Cisplatin Dose of Concurrent and Induction/Adjuvant Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma
Wai-Tong Ng; Cheuk-Wai Choi; Barton But; Roger K.C. Ngan; Stewart Tung; Ashley C. Cheng; Dora L.W. Kwong; Tai-Xiang Lu; Anthony T.C. Chan; Harry Yiu; Sarah Lee; Frank Wong; Kam-Tong Yuen; Richard J. Chappell; Anne W.M. Lee
Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma
Philip A. Philip; Ibrahim Azar; Joanne Xiu; Michael J. Hall; Andrew Eugene Hendifar; Emil Lou; Jimmy J. Hwang; Jun Gong; Rebecca Feldman; Michelle Ellis; Phil Stafford; David Spetzler; Moh'd M. Khushman; Davendra Sohal; A. Craig Lockhart; Benjamin A. Weinberg; Wafik S. El-Deiry; John Marshall; Anthony F. Shields; W. Michael Korn
Correction
Correction: GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer
Grainne M. O'Kane; Barbara T. Grünwald; Gun-Ho Jang; Mehdi Masoomian; Sarah Picardo; Robert C. Grant; Robert E. Denroche; Amy Zhang; Yifan Wang; Jessica K. Miller; Bernard Lam; Paul M. Krzyzanowski; Ilinca M. Lungu; John M.S. Bartlett; Melanie Peralta; Foram Vyas; Rama Khokha; James Biagi; Dianne Chadwick; Stephanie Ramotar; Shawn Hutchinson; Anna Dodd; Julie M. Wilson; Faiyaz Notta; George Zogopoulos; Steven Gallinger; Jennifer J. Knox; Sandra E. Fischer
Advertisement
